Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20107498 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety of and Immune Response to a Malaria Vaccine (MSP1 42-C1) With or Without CPG 7909 Adjuvant
Condition: Malaria
Interventions: Biological: MSP1 42-C1/Alhydrogel;   Biological: CPG 7909

Indicates status has not been verified in more than two years